AMPE vs. ALLR, SXTC, APVO, ADTX, OBSV, BLPH, SBFM, ATHX, EVLO, and SPRC
Should you be buying Ampio Pharmaceuticals stock or one of its competitors? The main competitors of Ampio Pharmaceuticals include Allarity Therapeutics (ALLR), China SXT Pharmaceuticals (SXTC), Aptevo Therapeutics (APVO), Aditxt (ADTX), ObsEva (OBSV), Bellerophon Therapeutics (BLPH), Sunshine Biopharma (SBFM), Athersys (ATHX), Evelo Biosciences (EVLO), and SciSparc (SPRC). These companies are all part of the "pharmaceutical preparations" industry.
Allarity Therapeutics (NASDAQ:ALLR) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability, community ranking and media sentiment.
In the previous week, Allarity Therapeutics had 2 more articles in the media than Ampio Pharmaceuticals. MarketBeat recorded 2 mentions for Allarity Therapeutics and 0 mentions for Ampio Pharmaceuticals. Allarity Therapeutics' average media sentiment score of 0.00 beat Ampio Pharmaceuticals' score of -0.01 indicating that Ampio Pharmaceuticals is being referred to more favorably in the news media.
Allarity Therapeutics received 1 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 50.00% of users gave Allarity Therapeutics an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.
Ampio Pharmaceuticals' return on equity of 0.00% beat Allarity Therapeutics' return on equity.
11.5% of Allarity Therapeutics shares are held by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 0.1% of Allarity Therapeutics shares are held by company insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Allarity Therapeutics has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 1.95, indicating that its share price is 95% more volatile than the S&P 500.
Summary
Allarity Therapeutics beats Ampio Pharmaceuticals on 6 of the 10 factors compared between the two stocks.
Get Ampio Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMPE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ampio Pharmaceuticals Competitors List
Related Companies and Tools
